ViraCyte's Incubator/Accelerator Round

ViraCyte raised a round of funding on February 01, 2016. Investors include JLabs.

ViraCyte is a clinical-stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for severe life-threatening infections. The company provides products that restore…

Articles about ViraCyte's Incubator/Accelerator Round: